Cáncer

The scientist proposes combating resistance in tumors with adaptive therapy: giving oncological drugs at the lowest possible dose

La Fundación Cris studies what to do with the 3.6 million raised after a media campaign that praised the results obtained in 45 mice

The organization withdraws the work in the journal PNAS and reproaches that the scientist and two colleagues did not declare that they own part of the company Vega Ocotargets for the commercial exploitation of the results